Home > Category > Signaling Pathways > Apoptosis > Apoptosis > Carfilzomib (Synonyms: PR-171)

(S)-4-甲基-N-((S)-1-(((S)-4-甲基-1-((R)-2-甲基氧基-2-基)-1-氧代戊烷-2-基)氨基)-1-氧代-3-苯基丙烷-2-基)-2-((S)-2-(2-吗啉乙酰氨基)-4-苯基丁胺基)戊酰胺;卡非佐米

ChemLeader 98+%
Catalog No:CL3040 CAS No.:868540-17-4 MDLNo:MFCD11040997 Formula:C40H57N5O7 MW:719.91
Size Availability Price(USD) VIP Price (USD) Quantity
5 mg In-stock ¥368.00 Visible after login
- +
10 mg In-stock ¥588.00 Visible after login
- +
25 mg In-stock ¥1068.00 Visible after login
- +
50 mg In-stock ¥1708.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Carfilzomib (Synonyms: PR-171)
CAS868540-17-4
FormulaC40H57N5O7
MW719.91
MDLMFCD11040997
AppearanceWhite to off-white powder
Storage conditionDry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Product details

Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM in ANBL-6 cells, displayed preferential in vitro inhibitory potency against the ChT-L activity in the β5 subunit, but little or no effect on the PGPH and T-L activities. Carfilzomib activates prosurvival autophagy and induces cell apoptosis.


This product is unstable in solution state. We recommend that you use it immediately.

Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays